A citation-based method for searching scientific literature

Mark E Robson, Angela R Bradbury, Banu Arun, Susan M Domchek, James M Ford, Heather L Hampel, Stephen M Lipkin, Sapna Syngal, Dana S Wollins, Noralane M Lindor. J Clin Oncol 2015
Times Cited: 289



Andrea Desmond, Allison W Kurian, Michele Gabree, Meredith A Mills, Michael J Anderson, Yuya Kobayashi, Nora Horick, Shan Yang, Kristen M Shannon, Nadine Tung, James M Ford, Stephen E Lincoln, Leif W Ellisen. JAMA Oncol 2015
Times Cited: 195




List of shared articles



Times cited

Economic impact of multigene panel testing for hereditary breast and ovarian cancer.
Stacey Dacosta Byfield, Helen Wei, Mary DuCharme, Johnathan M Lancaster. J Comp Eff Res 2021
0

Time Trends in Receipt of Germline Genetic Testing and Results for Women Diagnosed With Breast Cancer or Ovarian Cancer, 2012-2019.
Allison W Kurian, Kevin C Ward, Paul Abrahamse, Irina Bondarenko, Ann S Hamilton, Dennis Deapen, Monica Morrow, Jonathan S Berek, Timothy P Hofer, Steven J Katz. J Clin Oncol 2021
1

Decision Making About Genetic Testing Among Women With a Personal and Family History of Breast Cancer.
Danika Scott, Sue Friedman, Melinda L Telli, Allison W Kurian. JCO Oncol Pract 2020
6

Clinical utility of hereditary cancer panel testing: Impact of PALB2, ATM, CHEK2, NBN, BRIP1, RAD51C, and RAD51D results on patient management and adherence to provider recommendations.
Valentina Vysotskaia, K Eerik Kaseniit, Leslie Bucheit, Kaylene Ready, Kristin Price, Katherine Johansen Taber. Cancer 2020
6

Longitudinal outcomes with cancer multigene panel testing in previously tested BRCA1/2 negative patients.
Angela R Bradbury, Brian L Egleston, Linda J Patrick-Miller, Neil Rustgi, Amanda Brandt, Jamie Brower, Laura DiGiovanni, Dominique Fetzer, Christopher Berkelbach, Jessica M Long,[...]. Clin Genet 2020
2

Genetic Predisposition to Breast and Ovarian Cancers: How Many and Which Genes to Test?
Davide Angeli, Samanta Salvi, Gianluca Tedaldi. Int J Mol Sci 2020
12